Globus Medical director proposes $3.13M share sale

Available on EDGAR 11/10/2026 - 03:11 PM EST Accepted by SEC EDGAR 11/10/2026 - 03:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Globus Medical Inc. director James Robert Tobin Jr. reported a proposed sale of 41,666 common shares, with an approximate market value of $3,129,392.00 and an approximate sale date of November 10, 2026. The securities information identifies Raymond James & Associates, Inc. as broker and lists the NYSE. Tobin acquired 41,666 shares from the issuer through a cashless stock option exercise dated November 10, 2026. The form also reports a September 15, 2026 sale of 30,000 common shares for gross proceeds of $2,235,950.00.

Key Figures

Shares proposed for sale: 41,666 common shares Approximate market value of proposed sale: $3,129,392.00 Shares outstanding: 110,041,596 shares +2 more

5 metrics

Shares proposed for sale 41,666 common shares Approximate sale date: November 10, 2026

Approximate market value of proposed sale $3,129,392.00 Proposed sale of common shares

Shares outstanding 110,041,596 shares Number listed in the securities information

Prior sale 30,000 common shares Sale reported for September 15, 2026

Gross proceeds from prior sale $2,235,950.00 Sale reported for September 15, 2026

Key Terms

Cashless Stock Option Exercise, Aggregate Market Value, Gross Proceeds

3 terms

Cashless Stock Option Exercise technical

"Nature of Acquisition Transaction: Cashless Stock Option Exercise"

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Gross Proceeds financial

"Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GMED shares is director James Robert Tobin Jr. proposing to sell?

James Robert Tobin Jr. reported a proposed sale of 41,666 common shares, with an approximate market value of $3,129,392.00 and an approximate sale date of November 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190128
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBUS MEDICAL INC
SEC File Number	001-35621
Address of Issuer	2560 GENERAL ARMISTEAD AVENUE AUDUBON PENNSYLVANIA 19403
Phone	610-930-1800
Name of Person for Whose Account the Securities are To Be Sold	TOBIN JAMES R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg, FL 33716	41666	3129392.00	110041596	11/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2026	Cashless Stock Option Exercise	Issuer			41666	11/10/2026	Cashless Option Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James R. Tobin Jr 9 Camel Back Ct Brentwood TN 37027	Common	09/15/2026	30000	2235950.00

144: Remarks and Signature

Remarks
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for James Robert Tobin Jr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)